Reblozyl vs. Procrit

• Are Reblozyl and Procrit the Same Thing?
• What Are Possible Side Effects of Reblozyl?
• What Are Possible Side Effects of Procrit?
• What Is Reblozyl?
• What Is Procrit?
• What Drugs Interact with Reblozyl?
• What Drugs Interact with Procrit?
• How Should Reblozyl Be Taken?
• How Should Procrit Be Taken?

Reblozyl (luspatercept-aamt) and Procrit (epoetin alfa) are used to treat different types of anemia.

Reblozyl is used to treat anemia in adult patients with beta thalassemia who require regular red blood cell (RBC) transfusions.

Procrit is used to treat anemia associated with kidney failure, HIV patients undergoing treatment, cancer patients undergoing therapy, and certain surgical patients.

Reblozyl is an erythroid maturation agent and Procrit is a glycoprotein.

Side effects of Reblozyl and Procrit that are similar include headache, bone pain, joint pain, fatigue, cough, diarrhea, dizziness, nausea, and high blood pressure (hypertension).

Side effects of Reblozyl that are different from Procrit include abdominal pain, influenza, high uric acid levels in the blood, and viral upper respiratory tract infection.

Side effects of Procrit that are different from Reblozyl include muscle pain or spasms, body aches, vomiting, trouble swallowing, swelling, depression, weight loss, sleep problems (insomnia), pain/tenderness/irritation where Procrit is injected, and cold symptoms (stuffy nose, sneezing, sore throat).

Both Reblozyl and Procrit may interact with other medicines.

Side effects of Reblozyl include:

• headache,
• bone pain,
• joint pain,
• fatigue,
• cough,
• abdominal pain,
• diarrhea,
• dizziness,
• nausea,
• influenza,
• high blood pressure (hypertension),
• high uric acid levels in the blood,
• viral upper respiratory tract infection, and
• cough

Common side effects of Procrit include:

• high blood pressure (hypertension),
• headache,
• joint pain,
• bone pain,
• muscle pain or spasms,
• body aches,
• nausea,
• vomiting,
• trouble swallowing,
• swelling,
• fatigue,
• dizziness,
• depression,
• diarrhea,
• weight loss,
• sleep problems (insomnia),
• pain/tenderness/irritation where Procrit is injected, or
• cold symptoms (stuffy nose, sneezing, cough, sore throat).

Serious side effects of Procrit include:

• blood clots,
• chest pain,
• seizures,
• strokes,
• heart attack, and
• death.

Reblozyl (luspatercept-aamt) is an erythroid maturation agent indicated for the treatment of anemia in adult patients with beta thalassemia who require regular red blood cell (RBC) transfusions.

Procrit (epoetin alfa) is a glycoprotein that stimulates red blood cell production used to treat anemia associated with kidney failure, HIV patients undergoing treatment, cancer patients undergoing therapy, and certain surgical patients.

Reblozyl may interact with other medicines.

Tell your doctor all medications and supplements you use.

Procrit may interact with other drugs.

Tell your doctor all medications and supplements you use.

The recommended starting dose of Reblozyl is 1 mg/kg once every 3 weeks by subcutaneous injection.

Procrit is available in vials; 1 mL of solution contains 2000, 3000, 4000 or 10,000 Units of Epoetin alfa. Single and multidose vials are available. Dose is determined by the prescribing doctor and the patient's condition.